• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Immunoassay Market

    ID: MRFR/HC/48525-HCR
    200 Pages
    Garvit Vyas
    September 2025

    South Korea Immunoassay Market Research Report By Type (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Fluorescent Immunoassay, Chemiluminescent Immunoassay, Western Blot), By Technology (Automated Immunoassay, Point of Care Immunoassay, Lateral Flow Assay), By Application (Clinical Diagnostics, Drug Development, Environmental Testing, Food Safety Testing) andBy End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Academic Research Institutions)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Immunoassay Market Research Report — Global Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    South Korea Immunoassay Market Summary

    The South Korea Immunoassay market is projected to grow from 505 USD Million in 2024 to 814 USD Million by 2035.

    Key Market Trends & Highlights

    South Korea Immunoassay Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.44 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 814 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 505 USD Million, reflecting a solid foundation for future expansion.
    • Growing adoption of immunoassay technologies due to increasing demand for rapid diagnostic solutions is a major market driver.

    Market Size & Forecast

    2024 Market Size 505 (USD Million)
    2035 Market Size 814 (USD Million)
    CAGR (2025-2035) 4.44%

    Major Players

    Beckman Coulter, Sysmex Corporation, DiaSorin, Eiken Chemical, Genscript Biotech, Abbott Laboratories, Hologic, BioRad Laboratories, Ortho Clinical Diagnostics, American BioProducts, Siemens Healthineers, Roche Diagnostics, Fujirebio, Thermo Fisher Scientific, Randox Laboratories

    South Korea Immunoassay Market Trends

    The South Korea immunoassay market is experiencing significant growth driven by the rising prevalence of chronic diseases and an increase in the demand for rapid diagnostic tests. The aging population in South Korea has heightened the need for early and accurate disease detection, leading to a surge in the adoption of immunoassay technologies. Additionally, government initiatives aimed at enhancing healthcare infrastructure and promoting research and development in biomedicine are pivotal market drivers. These initiatives include substantial funding for biotech firms and partnerships with global health organizations to advance diagnostic capabilities.

    Recent trends show clear movement toward enabling point-of-care testing solutions, allowing faster result retrieval by healthcare providers, which enhances patient care. The need for quick testing during the COVID-19 pandemic certainly accelerated innovation in the industry, further fueling the trend. Another notable trend is the growing use of automated immunoassay analyzers in laboratories, as they enhance productivity and decrease human errors. The encouragement of digital health initiatives by the South Korean government stands as another opportunity to be addressed because it promotes the development of comprehensive healthcare systems that merge immunoassays with other digital technologies.

    Moreover, the focus on personalized medicine in South Korea is fostering new opportunities for immunoassay applications, particularly in oncology. As healthcare evolves to be more patient-centric, the ability to tailor diagnostics to individual patient needs is becoming increasingly valuable. This is paving the way for more precise and effective treatment regimens, enhancing the overall quality of healthcare in South Korea. Overall, the South Korea immunoassay market is set for continued advancement, driven by both current healthcare demands and technological innovation.

    South Korea Immunoassay Market Drivers

    Market Segment Insights

    Immunoassay Market Type Insights

    The South Korea Immunoassay Market is characterized by a diverse range of types that play crucial roles in laboratory diagnostics. The dominant player in this landscape is the Enzyme-Linked Immunosorbent Assay (ELISA), known for its versatility, high specificity, and potential for mass screening applications, making it a favored choice for serological tests and biomarker validation.

    Close on its heels, the Radioimmunoassay (RIA) technique holds significance due to its high sensitivity, particularly in hormone and drug level measurements, despite facing regulatory challenges in recent years concerning radioactive materials. The Fluorescent Immunoassay (FIA) segment is increasingly gaining traction due to its rapid results and ease of automation, aligning well with South Korea's advanced technological capabilities in diagnostics.

    Chemiluminescent Immunoassay (CLIA) shows promising growth, attributed to its higher detection limits and a diverse range of analytes. This method is particularly appreciated in clinical laboratories for its reduced turnaround time and increased throughput. Lastly, the Western Blot technique remains vital in confirming diagnoses, often utilized in fields like infectious disease testing, where accurate results are paramount.

    The interplay among these various types reflects the vibrant ecosystem of the South Korea Immunoassay Market, which is poised for growth driven by innovations in diagnostic technology and the increasing prevalence of diseases requiring accurate and efficient testing solutions. Each type contributes uniquely, thereby shaping the future landscape of the diagnostic industry in South Korea, supported by government initiatives to enhance healthcare standards and testing capabilities. The consistent advancements and adaptations among these immunoassay types indicate a dynamic and responsive industry that effectively meets the evolving needs of both healthcare providers and patients.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Immunoassay Market Technology Insights

    The Technology segment of the South Korea Immunoassay Market is characterized by advanced methodologies that enhance diagnostics and patient care. Among the prominent technologies are Automated Immunoassays, which streamline testing processes in laboratory settings, resulting in increased efficiency and throughput. These systems are essential for high-volume testing facilities, ensuring rapid results while maintaining accuracy.

    Point of Care Immunoassays play a crucial role in healthcare delivery by allowing immediate testing at the patient's location, thereby empowering quicker decision-making in clinical settings. This technology is particularly vital in critical situations where timely diagnosis can significantly affect patient outcomes.

    Lateral Flow Assays, known for their simplicity and ease of use, dominate market preferences for rapid tests due to their portability and cost-effectiveness. They are particularly valuable for at-home testing and widespread screening applications, making them a significant asset in disease management strategies. Overall, these diverse approaches within the Technology segment enable the South Korea Immunoassay Market to meet evolving healthcare demands while advancing diagnostic capabilities across various settings.

    Immunoassay Market Application Insights

    The South Korea Immunoassay Market is significantly shaped by its Application segment, which includes various essential areas such as Clinical Diagnostics, Drug Development, Environmental Testing, and Food Safety Testing. Clinical Diagnostics holds a crucial role in disease detection and patient monitoring, enhancing healthcare outcomes across the country. With growing investments in healthcare infrastructure, the demand for innovative diagnostic solutions continues to rise.

    Drug Development is also pivotal as it facilitates the creation and assessment of new therapies, ensuring the efficiency and safety of pharmaceutical products. In a country known for its advanced Research and Development facilities, this segment thrives on strict regulatory standards and innovative technologies.

    Environmental Testing is increasingly gaining traction, driven by the growing awareness of environmental safety and governmental regulations. In South Korea, where rapid industrial growth impacts environmental quality, effective testing methods are essential for public health monitoring. Lastly, Food Safety Testing plays a significant role in ensuring consumer safety and addressing the growing concerns about foodborne illnesses and contamination, which in turn supports a robust agricultural sector.

    The overall dynamics of these segments reflect South Korea's commitment to advancing health, safety, and environmental sustainability through effective immunoassay applications.

    Immunoassay Market End Use Insights

    The South Korea Immunoassay Market is notably supported by various end-use categories such as Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, and Academic Research Institutions. Hospitals play a crucial role, given their need for accurate and rapid diagnostic tests to enhance patient care and streamline treatment protocols.

    Diagnostic Laboratories dominate this segment by offering specialized testing services that enable precise disease detection and monitoring, which is increasingly vital in the healthcare landscape. Pharmaceutical Companies leverage immunoassay technologies for drug development and therapeutic monitoring, aligning their research with the growing demand for personalized medicine.

    Furthermore, Academic Research Institutions contribute significantly by utilizing these methods in innovative studies aimed at improving disease understanding and treatment methodologies. The collaborative efforts between these sectors reflect a robust ecosystem that drives advancements and fosters growth in the South Korea Immunoassay Market, addressing both clinical and research needs effectively. With an increasing focus on healthcare quality and research excellence, opportunities for innovation and expansion within these end-user categories appear promising.

    Get more detailed insights about South Korea Immunoassay Market Research Report — Global Forecast till 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The South Korea Immunoassay Market is characterized by a dynamic and competitive landscape driven by the increasing demand for precise diagnostic tools and technologies within the healthcare sector. With advancements in assay technology, the market is rapidly evolving, with a focus on improving accuracy, speed, and the range of detectable conditions. The landscape features various key players competing fiercely to establish their foothold, with an emphasis on innovation, research and development, and strategic collaborations.

    Manufacturers are not only looking to expand their product offerings but are also focusing on developing user-friendly platforms and enhancing the efficiency of testing processes to meet the needs of medical professionals and patients alike. Regulatory frameworks and evolving healthcare policies are also shaping competitive strategies in the market as companies seek to align themselves with compliance requirements while maximizing patient accessibility to their products.

    Key Company Profiles

    Beckman Coulter

    Beckman Coulter is a significant player in the South Korea Immunoassay Market, leveraging its established reputation for producing high-quality diagnostic instruments and reagents. The company has built a strong market presence through its innovative range of immunoassay analyzers, which are widely recognized for their accuracy and reliability.

    Beckman Coulter's strengths lie in its commitment to research and development, allowing it to introduce cutting-edge technologies that cater specifically to the diagnostic needs of healthcare providers in South Korea. By continually enhancing its product line and investing in customer support, the company has successfully positioned itself as a trusted partner in achieving better patient outcomes. Its focus on the integration of automation and user-friendly interfaces has also contributed significantly to its competitive edge within the region.

    Sysmex Corporation

    Sysmex Corporation also possesses a notable presence in the South Korea Immunoassay Market, where it delivers a diverse range of diagnostic solutions focused predominantly on hematology and immunochemistry. The company has gained a strong foothold through its advanced proprietary technologies and its commitment to innovation.

    Sysmex provides various key products and services, including fully automated immunoassay analyzers and reagents designed to deliver fast and accurate diagnostic results for various clinical applications. Its strengths lie in its robust research capabilities and strategic collaborations, which have facilitated the expansion of its product offerings tailored to meet local market demands. Additionally, Sysmex has engaged in mergers and acquisitions to enhance its technological capabilities and market reach in South Korea, further solidifying its position in the competitive landscape.

    Its dedication to improving healthcare through diagnostic innovation contributes to its stature as a prominent player in the immunoassay market of the region.

    Key Companies in the South Korea Immunoassay Market market include

    Industry Developments

    Recent developments in the South Korea Immunoassay Market indicate a growing interest in advanced diagnostic technologies amidst increasing healthcare demands. Beckman Coulter and Abbott Laboratories have been expanding their product offerings, focusing on point-of-care testing and automation, which aligns with the country's drive for efficient healthcare solutions.

    Furthermore, Sysmex Corporation has recently seen significant growth in its hematology and immunoassay markets due to rising chronic disease prevalence in South Korea. In terms of mergers and acquisitions, Roche Diagnostics completed its acquisition of an unidentified local immunoassay company in April 2023, bolstering its market position.

    Additionally, DiaSorin announced strategic collaborations with local firms to enhance its portfolio in the region as of June 2022, indicating an active interest in localized partnerships. Over the last few years, the market has been influenced by the COVID-19 pandemic, with an enhanced focus on rapid testing solutions driving innovation. Reports have highlighted an increase in market valuations for companies like Hologic and Siemens Healthineers, reflecting a robust demand for immunoassay technologies. Overall, the South Korean market continues to evolve with significant investments and advancements tailored to meet its healthcare challenges.

    Market Segmentation

    Immunoassay Market Type Outlook

    • Enzyme-Linked Immunosorbent Assay
    • Radioimmunoassay
    • Fluorescent Immunoassay
    • Chemiluminescent Immunoassay
    • Western Blot

    Immunoassay Market End Use Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Pharmaceutical Companies
    • Academic Research Institutions

    Immunoassay Market Technology Outlook

    • Automated Immunoassay
    • Point of Care Immunoassay
    • Lateral Flow Assay

    Immunoassay Market Application Outlook

    • Clinical Diagnostics
    • Drug Development
    • Environmental Testing
    • Food Safety Testing

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 486.23(USD Million)
    MARKET SIZE 2024 505.0(USD Million)
    MARKET SIZE 2035 814.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.436% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Beckman Coulter, Sysmex Corporation, DiaSorin, Eiken Chemical, Genscript Biotech, Abbott Laboratories, Hologic, BioRad Laboratories, Ortho Clinical Diagnostics, American BioProducts, Siemens Healthineers, Roche Diagnostics, Fujirebio, Thermo Fisher Scientific, Randox Laboratories
    SEGMENTS COVERED Type, Technology, Application, End Use
    KEY MARKET OPPORTUNITIES Rising demand for rapid testing, Expansion of point-of-care testing, Increasing prevalence of chronic diseases, Growth in personalized medicine, Advancements in technology and automation
    KEY MARKET DYNAMICS Rising prevalence of chronic diseases, Increasing demand for rapid diagnostics, Technological advancements in testing methods, Growing geriatric population, Expansion of healthcare infrastructure
    COUNTRIES COVERED South Korea

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market size of the South Korea Immunoassay Market in 2024?

    The South Korea Immunoassay Market is expected to be valued at 505.0 million USD in 2024.

    What will the South Korea Immunoassay Market be valued at by 2035?

    By 2035, the South Korea Immunoassay Market is projected to reach a value of 814.0 million USD.

    What is the expected CAGR for the South Korea Immunoassay Market from 2025 to 2035?

    The expected CAGR for the South Korea Immunoassay Market between 2025 and 2035 is 4.436%.

    Which type of immunoassay is projected to dominate the market by 2035?

    The Enzyme-Linked Immunosorbent Assay is projected to dominate the market with a valuation of 250.0 million USD by 2035.

    What will the market value for the Chemiluminescent Immunoassay be in 2035?

    The market value for Chemiluminescent Immunoassay is expected to grow to 210.0 million USD by 2035.

    Who are the major players in the South Korea Immunoassay Market?

    Major players include Beckman Coulter, Sysmex Corporation, Abbott Laboratories, and Roche Diagnostics among others.

    What is the expected market value of Radioimmunoassay in 2024?

    The expected market value for Radioimmunoassay in 2024 is 90.0 million USD.

    What will be the market size for Fluorescent Immunoassay in 2035?

    The market size for Fluorescent Immunoassay is projected to reach 135.0 million USD by 2035.

    What market challenges might the South Korea Immunoassay Market face?

    Challenges may include regulatory changes and the need for technological advancements in immunoassay methods.

    What opportunities exist in the South Korea Immunoassay Market?

    Opportunities include the increasing demand for early disease detection and advancements in diagnostic technology.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. South Korea Immunoassay Market, BY Type (USD Million)
    45. Enzyme-Linked Immunosorbent Assay
    46. Radioimmunoassay
    47. Fluorescent Immunoassay
    48. Chemiluminescent Immunoassay
    49. Western Blot
    50. South Korea Immunoassay Market, BY Technology (USD Million)
    51. Automated Immunoassay
    52. Point of Care Immunoassay
    53. Lateral Flow Assay
    54. South Korea Immunoassay Market, BY Application (USD Million)
    55. Clinical Diagnostics
    56. Drug Development
    57. Environmental Testing
    58. Food Safety Testing
    59. South Korea Immunoassay Market, BY End Use (USD Million)
    60. Hospitals
    61. Diagnostic Laboratories
    62. Pharmaceutical Companies
    63. Academic Research Institutions
    64. Competitive Landscape
    65. Overview
    66. Competitive Analysis
    67. Market share Analysis
    68. Major Growth Strategy in the Immunoassay Market
    69. Competitive Benchmarking
    70. Leading Players in Terms of Number of Developments in the Immunoassay Market
    71. Key developments and growth strategies
    72. New Product Launch/Service Deployment
    73. Merger & Acquisitions
    74. Joint Ventures
    75. Major Players Financial Matrix
    76. Sales and Operating Income
    77. Major Players R&D Expenditure. 2023
    78. Company Profiles
    79. Beckman Coulter
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Sysmex Corporation
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. DiaSorin
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Eiken Chemical
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Genscript Biotech
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Abbott Laboratories
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Hologic
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. BioRad Laboratories
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Ortho Clinical Diagnostics
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. American BioProducts
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Siemens Healthineers
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Roche Diagnostics
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Fujirebio
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Thermo Fisher Scientific
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Randox Laboratories
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. References
    170. Related Reports
    171. South Korea Immunoassay Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    172. South Korea Immunoassay Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    173. South Korea Immunoassay Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    174. South Korea Immunoassay Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    175. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    176. ACQUISITION/PARTNERSHIP
    177. MARKET SYNOPSIS
    178. SOUTH KOREA IMMUNOASSAY MARKET ANALYSIS BY TYPE
    179. SOUTH KOREA IMMUNOASSAY MARKET ANALYSIS BY TECHNOLOGY
    180. SOUTH KOREA IMMUNOASSAY MARKET ANALYSIS BY APPLICATION
    181. SOUTH KOREA IMMUNOASSAY MARKET ANALYSIS BY END USE
    182. KEY BUYING CRITERIA OF IMMUNOASSAY MARKET
    183. RESEARCH PROCESS OF MRFR
    184. DRO ANALYSIS OF IMMUNOASSAY MARKET
    185. DRIVERS IMPACT ANALYSIS: IMMUNOASSAY MARKET
    186. RESTRAINTS IMPACT ANALYSIS: IMMUNOASSAY MARKET
    187. SUPPLY / VALUE CHAIN: IMMUNOASSAY MARKET
    188. IMMUNOASSAY MARKET, BY TYPE, 2025 (% SHARE)
    189. IMMUNOASSAY MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    190. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    191. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    192. IMMUNOASSAY MARKET, BY APPLICATION, 2025 (% SHARE)
    193. IMMUNOASSAY MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    194. IMMUNOASSAY MARKET, BY END USE, 2025 (% SHARE)
    195. IMMUNOASSAY MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    196. BENCHMARKING OF MAJOR COMPETITORS

    South Korea Immunoassay Market Segmentation

     

     

     

    • Immunoassay Market By Type (USD Million, 2019-2035)

      • Enzyme-Linked Immunosorbent Assay
      • Radioimmunoassay
      • Fluorescent Immunoassay
      • Chemiluminescent Immunoassay
      • Western Blot

     

    • Immunoassay Market By Technology (USD Million, 2019-2035)

      • Automated Immunoassay
      • Point of Care Immunoassay
      • Lateral Flow Assay

     

    • Immunoassay Market By Application (USD Million, 2019-2035)

      • Clinical Diagnostics
      • Drug Development
      • Environmental Testing
      • Food Safety Testing

     

    • Immunoassay Market By End Use (USD Million, 2019-2035)

      • Hospitals
      • Diagnostic Laboratories
      • Pharmaceutical Companies
      • Academic Research Institutions

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027